NCT02714790

Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia

Ruolo Prognostico Della Malattia Minima Residua Nella Leucemia Mieloide Acuta

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 281 (actual)
• Sponsor: A.O.U. Città della Salute e della Scienza · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

Study purpose is to assess the prognostic role of Minimal Residual Disease (defined as medullary expression of WT1 gene), performed at Baseline and during treatment according to clinical practice. MRD results will be relate to treatment outcome and survival analysis variables (Overall Survival, Disease Free Survival, Cumulative Incidence of Relapse)

Conditions

• Acute Myeloid Leukemia
• Minimal Residual Disease
• Wilms Tumor

Timeline

• Start date: 2015-05-01
• Primary completion: 2015-06-01
• Completion: 2015-06-01
• First posted: 2016-03-22
• Last updated: 2016-03-23